Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: Switzerland Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20073
20082
20101
20113
20122
20131
20143
20151
20171
20181
20192
20201
20214
20231
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting8
Recruiting7
Terminated3
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Swiss Cancer Institute5
AstraZeneca4
European Organisation for Research and Treatment of Cancer - EORTC3
Novartis Pharmaceuticals3
Amgen2
ABX advanced biochemical compounds GmbH1
Abbott1
Astellas Pharma Europe Ltd.1
Bayer1
Ente Ospedaliero Cantonale, Bellinzona1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms35
Neoplasm Metastasis5
Neoplasms4
Breast Neoplasms1
Carcinoma1
Genital Diseases, Male1
Genital Neoplasms, Male1
Male Urogenital Diseases1
Neoplasms by Site1
Prostatic Diseases1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.